SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling.
Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, Zi Y, Gao J, Mu Y, Guan Y, Cao Z, Wang X, Pei Q, Zeng Y, Fan Q, Zeng Z, Ou D, He J, Nie Y, Tan R, Weng L, Li Y, Xiang R, Deng Y, Sun L.
Rong Z, et al. Among authors: gao j.
Oncogene. 2022 Apr;41(16):2390-2403. doi: 10.1038/s41388-022-02259-0. Epub 2022 Mar 11.
Oncogene. 2022.
PMID: 35277657